NGM Biopharmaceuticals, Inc. (NGM) has 12 identified peers for comparison in the Healthcare sector. Peers include ACHL, ASMB, CCCC, CYT, ERAS, FHTX and others.
NGM has a market capitalization of $128.53M, compared to an average peer market cap of $776.46M. NGM is notably smaller than its average peer.
